{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:53Z","timestamp":1772166293974,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although controversial, there are data suggesting that clinical parameters can predict the probability of sphincter preserving procedures in rectal cancer. The purpose of this study was to investigate the association between clinical parameters and the sphincter-preserving surgery rate in patients who had undergone neoadjuvant combination therapy for advanced low rectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single center study, the charts of 540 patients with locally advanced rectal cancer who had been treated with induction chemotherapy-and\/or neoadjuvant concomitant radiochemotherapy (nRCT) over an 11-year period were reviewed in order to identify patients with rectal cancer \u22646\u2009cm from the anal verge, who had received the prescribed nRCT only. Univariate and multivariate analyses were used to identify pretreatment patient- and tumor associated parameters correlating with sphincter preservation. Survival rates were calculated using Kaplan-Meier analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two hundred eighty of the 540 patients met the selection criteria. Of the 280 patients included in the study, 158 (56.4%) underwent sphincter-preserving surgery. One hundred sixty-four of 280 patients (58.6%) had a downsizing of the primary tumor (ypT\u2009&lt;\u2009cT) and 39 (23.8%) of these showed a complete histopathological response (ypT0 ypN0). In univariate analysis, age prior to treatment, Karnofsky performance status, clinical T-size, relative lymphocyte value, CRP value, and interval between nRCT and surgery, were significantly associated with sphincter-preserving surgery. In multivariate analysis, age (hazard ratio (HR)\u2009=\u20091.05, CI95%: 1.02\u20131.09,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), relative lymphocyte value (HR\u2009=\u20090.94, CI95%: 0.89\u20130.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029), and interval between nRCT and surgery (HR\u2009=\u20092.39, CI95%: 1.17\u20134.88,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016) remained as independent predictive parameters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These clinical parameters can be considered in the prognostication of sphincter-preserving surgery in case of low rectal adenocarcinoma. More future research is required in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-020-01554-y","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T08:04:25Z","timestamp":1588752265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical parameters predictive for sphincter-preserving surgery and prognostic outcome in patients with locally advanced low rectal cancer"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9132-012X","authenticated-orcid":false,"given":"Richard","family":"Partl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marton","family":"Magyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Langsenlehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin Sigrid","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"7","key":"1554_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.6004\/jnccn.2018.0061","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Cederquist L, et al. Rectal Cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(7):874\u2013901. https:\/\/doi.org\/10.6004\/jnccn.2018.0061.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"1554_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12957-017-1275-4","volume":"15","author":"E Akgun","year":"2017","unstructured":"Akgun E, Ozkok S, Tekin M, et al. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. World J Surg Oncol. 2017;15(1):205. https:\/\/doi.org\/10.1186\/s12957-017-1275-4.","journal-title":"World J Surg Oncol"},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731\u201340.","journal-title":"N Engl J Med"},{"issue":"4","key":"1554_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clcc.2015.06.001","volume":"14","author":"D Armstrong","year":"2015","unstructured":"Armstrong D, Raissouni S, Price Hiller J, et al. Predictors of pathologic complete response after Neoadjuvant treatment for rectal Cancer: a multicenter study. Clin Colorectal Cancer. 2015;14(4):291\u20135. https:\/\/doi.org\/10.1016\/j.clcc.2015.06.001.","journal-title":"Clin Colorectal Cancer"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/cncr.11075","volume":"97","author":"CH Crane","year":"2003","unstructured":"Crane CH, Skibber JM, Feig BW, et al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003;97:517\u201324.","journal-title":"Cancer"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/cancers3022176","volume":"3","author":"G Spolverato","year":"2011","unstructured":"Spolverato G, Pucciarelli S, Bertorelle R, et al. Review: predictive factors of response of rectal Cancer to Neoadjuvant Radiochemotherapy. Cancers. 2011;3:2176\u201394. https:\/\/doi.org\/10.3390\/cancers3022176.","journal-title":"Cancers"},{"issue":"110\u2013111","key":"1554_CR7","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.5754\/hge11133","volume":"58","author":"K Lu","year":"2011","unstructured":"Lu K, Zhu Y, Sheng L, et al. Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer. Hepatogastroenterology. 2011;58(110\u2013111):1507\u201310. https:\/\/doi.org\/10.5754\/hge11133. Epub 2011 Jul 15. PMID: 21940318.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"1554_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00384-010-1054-y","volume":"26","author":"K Kawai","year":"2011","unstructured":"Kawai K, Kitayama J, Tsuno NH, et al. Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer. Int J Color Dis. 2011;26(1):45\u201351. https:\/\/doi.org\/10.1007\/s00384-010-1054-y.","journal-title":"Int J Color Dis"},{"issue":"4","key":"1554_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00384-012-1594-4","volume":"28","author":"K Kawai","year":"2013","unstructured":"Kawai K, Kitayama J, Tsuno NH, et al. Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer. Int J Color Dis. 2013;28(4):527\u201335. https:\/\/doi.org\/10.1007\/s00384-012-1594-4.","journal-title":"Int J Color Dis"},{"key":"1554_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijrobp.2010.02.025","volume":"80","author":"L Moureau-Zabotto","year":"2011","unstructured":"Moureau-Zabotto L, BertrandFarnault B, Chaisemartin C, et al. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2011;80:483\u201391. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.02.025.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"1554_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/DCR.0b013e31828e5a72","volume":"56","author":"U Wallin","year":"2013","unstructured":"Wallin U, Rothenberger D, Lowry A, et al. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Dis Colon Rectum. 2013;56(7):859\u201368. https:\/\/doi.org\/10.1097\/DCR.0b013e31828e5a72.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"1554_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3349\/ymj.2015.56.6.1461","volume":"56","author":"NK Kim","year":"2015","unstructured":"Kim NK, Hur H. New perspectives on predictive biomarkers of tumor response and their clinical application in preoperative Chemoradiation therapy for rectal Cancer. Yonsei Med J. 2015;56(6):1461\u201377. https:\/\/doi.org\/10.3349\/ymj.2015.56.6.1461.","journal-title":"Yonsei Med J"},{"key":"1554_CR13","doi-asserted-by":"publisher","unstructured":"Sun Y, Zhang Y, Huang Z, et al. Combination of preoperative plasma fibrinogen and neutrophil-to-lymphocyte ratio (the F-NLR score) as a prognostic marker of locally advanced rectal Cancer following preoperative Chemoradiotherapy. World J Surg. 2020;4. https:\/\/doi.org\/10.1007\/s00268-020-05407-3. [Epub ahead of print].","DOI":"10.1007\/s00268-020-05407-3"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0360-3016(00)00732-X","volume":"48","author":"M Mohiuddin","year":"2000","unstructured":"Mohiuddin M, Hayne M, Regine WF, et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced\/recurrent rectal cancers. Int J Radiat Oncol Biol Phys. 2000;48:1075\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1554_CR15","doi-asserted-by":"publisher","first-page":"CD006041","DOI":"10.1002\/14651858.CD006041.pub3","volume":"28","author":"L De Caluw\u00e9","year":"2013","unstructured":"De Caluw\u00e9 L, Van Nieuwenhove Y, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2013;28:CD006041. https:\/\/doi.org\/10.1002\/14651858.CD006041.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1554_CR16","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1245\/s10434-013-3198-9","volume":"20","author":"NN Rahbari","year":"2013","unstructured":"Rahbari NN, Elbers H, Askoxylakis V, et al. Neoadjuvant radiotherapy for rectal cancer: metaanalysis of randomized controlled trials. Ann Surg Oncol. 2013;20:4169\u201382.","journal-title":"Ann Surg Oncol"},{"key":"1554_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2006.04.012","volume":"80","author":"K Bujko","year":"2006","unstructured":"Bujko K, Kepka L, Michalski W, et al. Does rectal cancer shrinkage induced by preoperative radio (chemo) therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol. 2006;80:4\u201312. https:\/\/doi.org\/10.1016\/j.radonc.2006.04.012.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1554_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3892\/etm.2015.2552","volume":"10","author":"Z Sun","year":"2015","unstructured":"Sun Z, Yu X, Wang H, et al. Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer. Exp Ther Med. 2015;10(2):484\u201390.","journal-title":"Exp Ther Med"},{"issue":"4","key":"1554_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.9738\/INTSURG-D-13-00217.1","volume":"99","author":"ZJ Cong","year":"2014","unstructured":"Cong ZJ, Hu LH, Xing JJ, et al. Risk factors associated with sphincter-preserving resection in patients with low rectal cancer. Int Surg. 2014;99(4):330\u20137. https:\/\/doi.org\/10.9738\/INTSURG-D-13-00217.1.","journal-title":"Int Surg"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/bjs.8677","volume":"99","author":"ST Martin","year":"2012","unstructured":"Martin ST, Heneghan HM, Winter DC. Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg. 2012;99:603\u201312.","journal-title":"Br J Surg"},{"issue":"2","key":"1554_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/SLA.0b013e3181ae330e","volume":"250","author":"LK Temple","year":"2009","unstructured":"Temple LK, Romanus D, Niland J, et al. Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann Surg. 2009;250(2):260\u20137. https:\/\/doi.org\/10.1097\/SLA.0b013e3181ae330e.","journal-title":"Ann Surg"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s00104-015-0083-z","volume":"86","author":"J Baral","year":"2015","unstructured":"Baral J,\u00b7Sch\u00f6n MR, Ruppert R, et al. Spincter preservation after selective chemoradiotherapy of rectal cancer. Interim results of the OCUM study. Chirurg 2015; 86:1138\u201344. https:\/\/doi.org\/10.1007\/s00104-015-0083-z.","journal-title":"Chirurg"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/DCR.0b013e31819f13a3","volume":"52","author":"JG Han","year":"2009","unstructured":"Han JG, Wei GH, Gao ZG, et al. Intersphincteric resection with direct coloanal anastomosis for ultralow rectal cancer:the experience of People\u2019s republic of China. Dis Colon Rectum. 2009;52:950\u20137.","journal-title":"Dis Colon Rectum"},{"key":"1554_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1463-1318.2008.01530.x","volume":"10","author":"HS Tilney","year":"2008","unstructured":"Tilney HS, Tekkis PP. Extending the horizons of restorative rectal surgery:intersphincteric resection for low rectal cancer. Color Dis. 2008;10:3\u201315. discussion 15-16.","journal-title":"Color Dis"},{"key":"1554_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/DCR.0b013e31819f5fa2","volume":"52","author":"K Yamada","year":"2009","unstructured":"Yamada K, Ogata S, Saiki Y, et al. Long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum. 2009;52:1065\u201371.","journal-title":"Dis Colon Rectum"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/bjs.8702","volume":"99","author":"ST Martin","year":"2012","unstructured":"Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918\u201328.","journal-title":"Br J Surg"},{"issue":"1","key":"1554_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y","volume":"52","author":"HE Ownby","year":"1983","unstructured":"Ownby HE, Roi LD, Isenberg RR, et al. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer. 1983;52(1):126\u201330.","journal-title":"Cancer."},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1748-717X-5-47","volume":"5","author":"J Kitayama","year":"2010","unstructured":"Kitayama J, Yasuda K, Kawai K, et al. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010;5:47.","journal-title":"Radiat Oncol"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2407-11-64","volume":"11","author":"J Kitayama","year":"2011","unstructured":"Kitayama J, Yasuda K, Kawai K, et al. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer. 2011;11:64. https:\/\/doi.org\/10.1186\/1471-2407-11-64.","journal-title":"BMC Cancer"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12957-014-0418-0","volume":"13","author":"N Tada","year":"2015","unstructured":"Tada N, Kawai K, Tsuno NH, et al. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets. World J Surg Oncol. 2015;13:30. https:\/\/doi.org\/10.1186\/s12957-014-0418-0.","journal-title":"World J Surg Oncol"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.radonc.2018.12.001","volume":"131","author":"H Liu","year":"2019","unstructured":"Liu H, Wang H, Wu J, et al. Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: immunologic relevance. Radiother Oncol. 2019;131:52\u20139.","journal-title":"Radiother Oncol"},{"key":"1554_CR32","doi-asserted-by":"publisher","unstructured":"Wu Z, Zhang J, Cai Y, et al. Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer. Medicine (Baltimore). 2018;97(38):e11435. https:\/\/doi.org\/10.1097\/MD.0000000000011435.","DOI":"10.1097\/MD.0000000000011435"},{"key":"1554_CR33","first-page":"1181","volume":"24","author":"H Tulchinsky","year":"2008","unstructured":"Tulchinsky H, Shmueli E, Figer A, et al. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol. 2008;24:1181\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1554_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ijrobp.2015.10.061","volume":"94","author":"E Cotte","year":"2016","unstructured":"Cotte E, Passot G, Decullier E, et al. Pathologic response, when increased by longer interval, is a marker but not the cause of good prognosis in rectal Cancer: 17-year follow-up of the Lyon R90-01 randomized trial. Int J Radiat Oncol Biol Phys. 2016;94(3):544\u201353. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.10.061.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","volume":"17","author":"Y Francois","year":"1999","unstructured":"Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17:2396.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1554_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1463-1318.2006.00990.x","volume":"8","author":"S Supiot","year":"2006","unstructured":"Supiot S, Bennouna J, Rio E, et al. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Color Dis. 2006;8(5):430\u20135. PMID: 16684088.","journal-title":"Color Dis"},{"issue":"2","key":"1554_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/SLA.0b013e31817fc2a0","volume":"248","author":"SB Lim","year":"2008","unstructured":"Lim SB, Choi HS, Jeong SY, et al. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg. 2008;248(2):243\u201351. https:\/\/doi.org\/10.1097\/SLA.0b013e31817fc2a0.","journal-title":"Ann Surg"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/bjs.5679","volume":"94","author":"L Pahlman","year":"2007","unstructured":"Pahlman L, Bohe M, Cedermark B, et al. The Swedish rectal cancer registry. Br J Surg. 2007;94:1285\u201392.","journal-title":"Br J Surg"},{"key":"1554_CR39","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.ejca.2008.11.039","volume":"45","author":"M den Dulk","year":"2009","unstructured":"den Dulk M, Putter H, Collette L, et al. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer. 2009;45:1175\u201383.","journal-title":"Eur J Cancer"},{"issue":"8","key":"1554_CR40","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.ejso.2018.04.008","volume":"44","author":"NPM Brouwer","year":"2018","unstructured":"Brouwer NPM, Stijns RCH, Lemmens VEPP, et al. Clinical lymph node staging in colorectal cancer; a flip of the coin? Eur J Surg Oncol. 2018;44(8):1241\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2018.04.008.","journal-title":"Eur J Surg Oncol"},{"key":"1554_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10350-004-0793-7","volume":"48","author":"H Purves","year":"2005","unstructured":"Purves H, Pietrobon R, Hervey S, et al. Relationship between surgeon caseload and sphincter preservation in patients with rectal cancer. Dis Colon Rectum. 2005;48:195\u2013204.","journal-title":"Dis Colon Rectum"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/jnci\/95.10.708","volume":"95","author":"DC Hodgson","year":"2003","unstructured":"Hodgson DC, Zhang W, Zaslawsky AM, et al. Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst. 2003;95:708\u201316.","journal-title":"J Natl Cancer Inst"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-020-01554-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T20:20:43Z","timestamp":1620246043000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01554-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01554-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-19261\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19261\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"23 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in the present study were in accordance with the ethical standards and written informed consent has been obtained for each patient. The study has been approved by the ethics committee of the Medical University of Graz (reference number 28\u2013046 ex 15\/16).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}